Articles by author - Klaudia Stangel-Wojcikiewicz

Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels.

Stangel-Wojcikiewicz K, Zdebik A, Jach R, Huras H, Wadowska-Jaszczynska K, Radon-Pokracka M, Kempisty-Zdebik E, Ludwin A, Ludwin I.

Journal Article 2012; 33(7): 697-702 PubMed PMID: 23391877  Keywords:  Adolescent, Adult, Chemoradiotherapy:adverse effects, Contraceptive Agents, Female:administration & dosage, Drug Combinations, Dydrogesterone:administration & dosage, Estradiol:administration & dosage, Estriol:administration & dosage, Female, Follicle Sti.    Citation

OBJECTIVES: Premature ovarian failure (POF) is a consequence of gonadotoxic chemoradiotherapy given in antyneoplasia treatment. In young w.....

Read abstract  Full text PDF

Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.

Jach R, Dyduch G, Radon-Pokracka M, Przybylska P, Mika M, Dulinska-Litewka J, Zajac K, Huras H, Streb J, Stangel-Wojcikiewicz K, Dziadek O, Galarowicz B.

Comparative Study 2011; 32(4): 530-539 PubMed PMID: 21876509  Keywords:  Adult, Aged, Antibodies:pharmacology, Biomarkers, Tumor:metabolism, Biopsy, Carcinoma in Situ:metabolism, Disease-Free Survival, Female, Humans, Lymphatic Vessels:immunology, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local:metabolism, Predi.    Citation

OBJECTIVE: The aim of this study was to compare the immunohistochemical expression of vascular endothelial growth factors VEGF-C and D, as.....

Read abstract  Full text PDF